Each filer's latest filing for 69353Y103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Tang Capital Management LLC
13G/A
|
10.0% |
11/16/2026
Event 9/30/2026
|
||
| Tang Capital Management, LLC | 10.0% | |||
| Kevin Tang | 10.0% | |||
| Tang Capital Partners, LP | 2.4% | |||
| Tang Capital Partners International, LP | 3.3% | |||
| Tang Capital Partners III, Inc | 2.3% | |||
| Tang Capital Partners IV, Inc | 2.0% | |||
|
Samsara BioCapital, L.P.
13G
|
9.9% |
9/15/2026
Event 9/2/2026
|
||
| Samsara BioCapital, L.P. | 5.0% | |||
| Samsara BioCapital GP, LLC | 5.0% | |||
| Samsara Opportunity Fund, L.P. | 5.0% | |||
| Samsara Opportunity Fund GP, LLC | 5.0% | |||
| Srinivas Akkaraju | 9.9% | |||
| BML Investment Partners, L.P. 13G/A | 9.9% |
2/9/2026
Event 12/31/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (5) | ||||
| Sio Capital Management, LLC 13G/A | 4.9% |
7/28/2026
Event 6/30/2026
|
||
|
Euclidean Capital LLC
13G/A
|
4.9% |
5/15/2026
Event 3/31/2026
|
||
| Euclidean Capital LLC | 4.9% | |||
| Marilyn H. Simons | 4.9% | |||
| Ashvin B. Chhabra | 4.9% | |||
| Greenland NFP B Ltd. | 2.4% | |||
| Greenland NFP LLC | 0.1% | |||
| Greenland A LLC | 0.7% | |||
| Symmetry Group Ltd. | 0.5% | |||
| ArrowMark Colorado Holdings LLC 13G/A | 3.7% |
7/10/2026
Event 6/30/2026
|
||
|
Orbimed Advisors LLC
13D/A
|
0% |
3/4/2026
Event 3/2/2026
|
||
| Orbimed Advisors LLC | 0% | |||
| Orbimed Capital GP V LLC | 0% | |||
|
PFM Health Sciences, LP
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| PFM Health Sciences, LP | 0% | |||
| PFM Health Sciences GP, LLC | 0% | |||
| Partner Asset Management, LLC | 0% | |||
| Brian D. Grossman | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 65 | 56.5 M | $94.4M |
| 2026 Q2 | 64 | 34.3 M | $45.9M |
| 2026 Q1 | 69 | 37.0 M | $45.8M |
| 2025 Q4 | 65 | 37.4 M | $46.8M |
| 2025 Q3 | 64 | 37.5 M | $52.5M |
| 2025 Q2 | 55 | 34.7 M | $36.8M |
| 2025 Q1 | 56 | 37.3 M | $40.7M |
| 2024 Q4 | 71 | 39.0 M | $58.8M |
| 2024 Q3 | 75 | 39.0 M | $58.2M |
| 2024 Q2 | 94 | 40.5 M | $65.6M |
| 2024 Q1 | 100 | 42.7 M | $72.7M |
| 2023 Q4 | 100 | 46.5 M | $144M |
| 2023 Q3 | 107 | 54.2 M | $333M |
| 2023 Q2 | 107 | 51.8 M | $324M |
| 2023 Q1 | 113 | 51.5 M | $246M |
| 2022 Q4 | 116 | 54.5 M | $474M |
| 2022 Q3 | 122 | 58.2 M | $692M |
| 2022 Q2 | 109 | 61.1 M | $871M |
| 2022 Q1 | 106 | 55.2 M | $1.15B |
| 2021 Q4 | 107 | 47.5 M | $1.10B |
| 2021 Q3 | 93 | 44.0 M | $1.31B |
| 2021 Q2 | 88 | 42.2 M | $1.44B |
| 2021 Q1 | 82 | 39.9 M | $1.31B |
| 2020 Q4 | 74 | 38.2 M | $2.34B |
| 2020 Q3 | 52 | 31.2 M | $1.10B |